| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000025757 |
| Receipt No. | R000020378 |
| Scientific Title | evaluation of serum carnitine concentration in patients with urological malignancy and the effect of levocarnitine to them |
| Date of disclosure of the study information | 2017/01/21 |
| Last modified on | 2022/06/13 (Ver. 5) |
| Basic information | ||
| Public title | evaluation of serum carnitine concentration in patients with urological malignancy and the effect of levocarnitine to them | |
| Acronym | the effect of levocarnitine to patients with urological malignancy | |
| Scientific Title | evaluation of serum carnitine concentration in patients with urological malignancy and the effect of levocarnitine to them | |
| Scientific Title:Acronym | the effect of levocarnitine to patients with urological malignancy | |
| Region |
|
|
| Condition | ||
| Condition | Oncology | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Measurement and replenishment of carnitine concentration |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Measurement of carnitine concentration |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | carnitine | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) urothelial carcinoma, prostate cancer, kidney carcinoma and testicular tumor disease
(2) Patients scheduled for chemotherapy treatment |
|||
| Key exclusion criteria | (1) A person who falls under the administration contraindication
(2) Persons undergoing dialysis, those with advanced renal dysfunction (3) Those who did not finally obtain consent (4) Others that other medical doctor deems inappropriate |
|||
| Target sample size | 80 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kawasaki Medical School | ||||||
| Division name | Urology | ||||||
| Zip code | 710-0192 | ||||||
| Address | Matsushima 577, Kurashiki City | ||||||
| TEL | 086-462-1111 | ||||||
| ryoeih@med.kawasaki-m.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kawasaki Medical School | ||||||
| Division name | Urology | ||||||
| Zip code | 710-0192 | ||||||
| Address | Matsushima 577, Kurashiki City | ||||||
| TEL | 086-462-1111 | ||||||
| Homepage URL | |||||||
| ryoeih@med.kawasaki-m.ac.jp | |||||||
| Sponsor | |
| Institute | Kawasaki Medical School |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Kawasaki Medical School |
| Address | Matsushima 577, Kurashiki City |
| Tel | 086-462-1111 |
| kmsrec@med.kawasaki-m.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020378 |